Neonatal Monitoring Sensor Adhesion and Skin Tolerance: Evidence, Challenges, and Clinical Best Practices

Abstract

Continuous monitoring of vital parameters in neonates is a cornerstone of modern neonatal intensive care, yet the use of adhesive sensors presents significant challenges for the delicate skin of this vulnerable population. This review synthesizes up-to-date evidence regarding the adhesion properties of neonatal monitoring sensors, mechanisms of skin injury, risk stratification, contemporary management strategies, and emerging technologies aimed at optimizing skin tolerance. Practical implications for clinical protocols and guideline-aligned recommendations are discussed to support safe and effective neonatal monitoring practices.

Introduction

Neonatal intensive care units (NICUs) rely on the continuous assessment of physiological parameters such as heart rate, oxygen saturation, and temperature using skin-adhered sensors. However, the application of adhesives on neonatal skin, especially in preterm and low-birth-weight infants, can result in adverse dermatological outcomes, including epidermal stripping, contact dermatitis, and in severe cases, infection. Understanding the interplay between sensor adhesion technology and neonatal skin physiology is essential for advancing patient safety, optimizing monitoring accuracy, and informing clinical guidelines.

Epidemiology / Disease Burden

Skin injuries associated with adhesive monitoring devices are among the most common iatrogenic complications in the NICU. Recent studies estimate that adhesive-related skin injuries occur in up to 25-30% of preterm infants during their hospital stay, with higher incidence rates in extremely low-birth-weight neonates. The disease burden extends beyond cutaneous manifestations, as skin injury increases the risk of nosocomial infections, prolongs hospitalization, and may have lasting effects on skin barrier function and overall morbidity.

Pathophysiology

Neonatal skin, particularly in premature infants, is structurally and functionally immature. The stratum corneum is thinner, there is reduced cohesion between epidermal layers, and the dermal-epidermal junction is less robust compared to older children and adults. These factors heighten susceptibility to mechanical trauma from adhesive removal, occlusion-induced maceration, and chemical irritation from sensor materials. Additionally, the high surface area-to-body weight ratio in neonates amplifies the impact of even minor injuries, compounding the risk of fluid and heat loss and secondary infection.

Risk Factors

Key risk factors for adhesive-related skin injury include gestational age below 32 weeks, birth weight under 1500 grams, prolonged sensor placement, frequent sensor repositioning, pre-existing dermatological conditions, and exposure to humidity or antiseptics under the adhesive. The choice of adhesive material, sensor design, and application technique further modulate risk. Individual variation in skin maturity and genetic predisposition to atopic or sensitive skin phenotypes may also contribute to differential tolerance.

Clinical Features

Clinical manifestations of sensor-induced skin injury encompass a spectrum from mild erythema and transient indentations to more severe presentations such as epidermal stripping, blistering, erosions, ulceration, and secondary infection. Early signs include localized redness and discomfort, which may progress to visible denudation or weeping lesions if unaddressed. Chronic or recurrent injury can lead to scarring or pigmentation changes. Assessment relies on regular inspection and standardized scoring systems, such as the Neonatal Skin Condition Score (NSCS), to quantify injury severity and guide intervention.

Diagnosis

Diagnosis of sensor-induced skin injury is primarily clinical, based on history of sensor application and characteristic lesion morphology. Distinguishing these injuries from other dermatologic conditions, such as congenital skin disorders or infectious lesions, is essential. Adjunctive diagnostic tools such as dermatoscopy or skin barrier function testing (transepidermal water loss, TEWL) may offer further insights in equivocal cases. Documentation of injury patterns and correlation with sensor type, adhesive formulation, and duration of application are important for quality improvement and device evaluation.

Treatment & Management

Management centers on prompt removal of offending devices, local wound care, and prevention of further trauma. Gentle adhesive removal using adhesive remover wipes, application of barrier films, and selection of atraumatic dressings are recommended. For established injuries, moist wound healing principles utilizing hydrogel or silicone-based dressings support re-epithelialization. Topical antimicrobials may be indicated in cases of secondary infection. Education of healthcare staff on proper sensor handling, rotation of sensor sites, and minimizing adhesive use are critical preventive strategies. Multidisciplinary collaboration with dermatology and wound care specialists enhances outcomes in complex or refractory cases.

Recent Advances / Emerging Therapies

Recent innovations target both the adhesive chemistry and sensor design. Hydrocolloid, silicone, and hydrogel-based adhesives demonstrate improved skin tolerance compared to traditional acrylic formulations. Low-tack, repositionable adhesives maintain sensor stability while reducing trauma at removal. There is increasing interest in non-adhesive sensor technologies, such as wireless, textile-integrated, or non-contact optoelectronic monitoring systems, which obviate the need for direct skin adhesion. Early clinical trials suggest these modalities offer comparable accuracy with substantially reduced risk of skin injury, though widespread adoption awaits further validation.

Guideline Recommendations

Evidence-based guidelines from neonatal and wound care societies advocate for the use of the least aggressive adhesive compatible with monitoring requirements, routine assessment of sensor sites, and scheduled rotation to minimize cumulative exposure. Preterm infants and those with prior skin injury warrant heightened vigilance and individualized sensor selection. Training programs emphasizing correct application, gentle removal, and early recognition of adverse skin reactions are recommended. Documentation and reporting of device-related injuries support quality assurance and inform procurement decisions for safer sensor technologies.

Conclusion

Optimizing sensor adhesion and skin tolerance is a fundamental aspect of safe and effective neonatal monitoring. Advances in adhesive materials and alternative sensor designs are reducing the incidence of skin injury, but continued vigilance, evidence-based practice, and interdisciplinary collaboration remain essential. A nuanced understanding of neonatal skin physiology, risk stratification, and emerging technologies will empower clinicians to deliver high-quality, skin-friendly monitoring and improve outcomes for this vulnerable patient population.